Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 12, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	22,949	22,121	18,246	19,473	11,199	9,068
Market Cap Growth	0.20%	21.24%	-6.30%	73.88%	23.50%	9.97%
Enterprise Value	22,768	20,903	16,178	17,504	9,587	7,890
Last Close Price	34.40	32.36	27.39	28.89	15.90	12.37
PE Ratio	28.44	25.28	24.67	28.89	18.49	15.27
Forward PE	23.32	22.87	22.87	22.87	16.30	15.49
PS Ratio	3.30	2.69	2.21	2.82	1.70	1.30
PB Ratio	4.13	3.33	2.78	2.99	1.88	1.64
P/TBV Ratio	3.90	3.56	2.96	3.16	2.00	1.74
P/FCF Ratio	25.53	40.40	32.05	28.00	23.22	31.28
P/OCF Ratio	20.09	32.13	26.94	22.84	16.68	18.30
EV/Sales Ratio	2.83	2.54	1.96	2.53	1.45	1.13
EV/EBITDA Ratio	24.55	22.63	20.58	24.96	14.51	12.62
EV/EBIT Ratio	28.58	26.15	24.10	29.82	17.40	14.94
EV/FCF Ratio	21.94	38.17	28.42	25.17	19.88	27.22
Debt / Equity Ratio	0.20	0.05	0.04	0.01	0.01	0.01
Debt / EBITDA Ratio	1.38	0.37	0.34	0.06	0.06	0.07
Debt / FCF Ratio	1.24	0.62	0.47	0.06	0.09	0.15
Asset Turnover	0.76	0.81	0.86	0.80	0.82	0.94
Inventory Turnover	2.60	3.09	3.38	2.76	2.61	2.79
Quick Ratio	1.05	1.51	1.71	1.81	1.85	1.54
Current Ratio	1.70	2.03	2.17	2.64	2.59	2.38
Return on Equity (ROE)	14.18%	14.68%	13.37%	12.63%	11.85%	12.01%
Return on Assets (ROA)	4.69%	4.90%	4.37%	4.23%	4.27%	4.42%
Return on Capital (ROIC)	6.63%	7.24%	6.27%	5.85%	5.96%	6.07%
Earnings Yield	3.52%	4.46%	4.72%	3.95%	5.91%	6.90%
FCF Yield	3.92%	2.48%	3.12%	3.57%	4.31%	3.20%
Dividend Yield	3.69%	3.96%	4.09%	1.73%	1.89%	2.43%
Payout Ratio	106.14%	88.91%	44.96%	30.17%	35.15%	27.71%
Buyback Yield / Dilution	0.51%	0.71%	-0.94%	0.04%	0.37%	-0.37%
Total Shareholder Return	4.20%	4.67%	3.15%	1.77%	2.26%	2.05%

Source: S&P Capital IQ. Standard template. Financial Sources.